Can tandem alternative splicing and evasion of premature termination codon surveillance contribute to attenuated Peutz-Jeghers syndrome?

Am J Med Genet A. 2022 Oct;188(10):3089-3095. doi: 10.1002/ajmg.a.62942. Epub 2022 Aug 10.

Abstract

Alternative use of short distance tandem sites such as NAGNn AG are a common mechanism of alternative splicing; however, single nucleotide variants are rarely reported as likely to generate or to disrupt tandem splice sites. We identify a pathogenic intron 5 STK11 variant (NM_000455.4:c.[735-6A>G];[=]) segregating with the mucocutaneous features but not the hamartomatous polyps of Peutz-Jeghers syndrome in two individuals. By RNAseq analysis of peripheral blood mRNA, this variant was shown to generate a novel and preferentially used tandem proximal splice acceptor (AAGTGAAG). The variant transcript (NM_000455.4:c.734_734 + 1insTGAAG), which encodes a frameshift (p.[Tyr246Glufs*43]) constituted 36%-43% of STK11 transcripts suggesting partial escape from nonsense mediated mRNA decay and translation of a truncated protein. A review of the ClinVar database identified other similar variants. We suggest that nucleotide changes creating or disrupting tandem alternative splice sites are a pertinent disease mechanism and require contextualization for clinical reporting. Additionally, we hypothesize that some pathogenic STK11 variants cause an attenuated phenotype.

Keywords: PJS; STK11; cryptic splice acceptor; nonsense mediated mRNA decay; tandem splice sites.

Publication types

  • Case Reports
  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • AMP-Activated Protein Kinase Kinases
  • Alternative Splicing
  • Codon, Nonsense
  • Humans
  • Nucleotides
  • Peutz-Jeghers Syndrome* / genetics
  • Peutz-Jeghers Syndrome* / pathology

Substances

  • Codon, Nonsense
  • Nucleotides
  • AMP-Activated Protein Kinase Kinases